Giuseppe Floresta Selected Research

Heterocyclic Compounds (Compounds, Heterocyclic)

9/2017

Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Floresta Research Topics

Disease

15	Neoplasms (Cancer) 10/2023 - 10/2017
4	Inflammation (Inflammations) 10/2022 - 09/2017
2	Carcinoma (Carcinomatosis) 08/2022 - 01/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2022 - 10/2018
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2019
1	Obesity 10/2023
1	Weight Loss (Weight Reduction) 10/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2022
1	Atopic Dermatitis (Atopic Eczema) 08/2022
1	Globoid Cell Leukodystrophy (Krabbe Disease) 08/2022
1	Psoriatic Arthritis 08/2022
1	Botulism 12/2020
1	Pathologic Processes 10/2020
1	Breast Neoplasms (Breast Cancer) 03/2020
1	Dystonic Disorders (Writer's Cramp) 01/2020
1	Migraine Disorders (Migraine) 01/2020
1	Dehydration (Water Stress) 01/2020
1	Hyperglycemia 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 10/2018
1	Melanoma (Melanoma, Malignant) 05/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2017
1	Atherosclerosis 09/2017

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2018
4	Heme Oxygenase-1IBA 01/2021 - 10/2018
3	Fatty Acid-Binding ProteinsIBA 10/2023 - 10/2022
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 09/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2023 - 04/2021
2	Tyrosine Kinase InhibitorsIBA 05/2022 - 10/2018
2	LigandsIBA 01/2022 - 10/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020 - 05/2018
2	EnzymesIBA 04/2019 - 10/2018
1	semaglutideIBA 10/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2023
1	IronIBA 07/2023
1	IntegrinsIBA 08/2022
1	ibudilastIBA 08/2022
1	RoflumilastIBA 08/2022
1	apremilastIBA 08/2022
1	crisaboroleIBA 08/2022
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 08/2022
1	Phosphodiesterase 4 InhibitorsIBA 08/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2022
1	Acarbose FDA LinkGeneric 12/2021
1	benzothiazoleIBA 12/2021
1	AmidesIBA 12/2021
1	Heme (Haem)IBA 01/2021
1	incobotulinumtoxinA FDA Link 12/2020
1	Type A Botulinum Toxins (Botox)FDA Link 12/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2020
1	PyrrolesIBA 05/2020
1	polypropylene glycol (poly(propylene oxide))IBA 05/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 05/2020
1	Hormones (Hormone)IBA 03/2020
1	cucurbit(7)urilIBA 01/2020
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	GlucosidasesIBA 01/2019
1	PolyphenolsIBA 01/2019
1	Rosmarinic AcidIBA 01/2019
1	AntioxidantsIBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 10/2018
1	Phosphotransferases (Kinase)IBA 10/2018
1	2- (2- methoxybenzyl)- 3- (1,10- phenanthrolin- 2- yl)isoxazolidin- 5- yl)methanolIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Intercalating AgentsIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Histone Deacetylase InhibitorsIBA 11/2017
1	romidepsin (FK228)FDA Link 11/2017
1	Vorinostat FDA Link 11/2017
1	Haloperidol (Haldol)FDA LinkGeneric 10/2017
1	ProdrugsIBA 10/2017
1	Urea (Carbamide)FDA LinkGeneric 09/2017
1	quinolineIBA 09/2017
1	Niacin (Nicotinic Acid)FDA LinkGeneric 09/2017
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 09/2017
1	pyridineIBA 09/2017
1	QuinoxalinesIBA 09/2017

Therapy/Procedure

1	Therapeutics 10/2018